Hong Kong stock Market anomaly | Hengrui Medicine (01276.HK) rose over 4%. Plans to submit HRS9531 injection for long-term weight management as a new drug application for listing in the near future.

According to the Securities Times app, CSPC Pharmaceutical Group (01276.HK) rose more than 4%, as of the time of publication, it rose by 3.96% to 74.8 Hong Kong dollars, with a turnover of 2168.98 million Hong Kong dollars.